French technology giant Dassault Systèmes has agreed to acquire Medidata, a life sciences digital transformation company in an all-cash deal for $92.25 per share valued at $5.8 billion. With the acquisition of Medidata and its clinical and commercial solutions, Dassault Systèmes plans to increase market penetration into the Life Sciences industry with an integrated business experience platform for an end-to-end approach to research and discovery, development, clinical testing, manufacturing and
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Revenue Cycle Startup Nym Lands $6M for Autonomous Medical Coding Solution
Nym, an Israeli-based autonomous medical coding technology provider announced that it has secured a $6 million seed funding, led by Bessemer Venture Partners. Founded in 2018 by Amihai Neiderman and Adam Rimon, Nym’s automatic medical language understanding technology streamlines the hospital revenue cycle.Traditional Cumbersome Medical Coding ProcessThere are over 250,000 medical coders in the United States today manually reviewing patient charts and assigning the applicable medical codes
Read More
Telegenomics Company Genome Medical Nabs $23M to Bring Genomic Medicine to Everyday Care
Genome Medical, a leading nationwide telegenomics company providing genomic-based medicine, today announced that it has raised $23 million in Series B financing to accelerate the development of its technology and medical services which support patients, physicians and healthcare systems in all 50 states. The Series B round was led by Echo Health Ventures, a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions with additional new investors LRVHealth, Casdin
Read More
Neurotrack Raises $21M for Digital Cognitive Health Platform
Neurotrack, a Redwood City, CA-based digital health company has raised $21 million in Series C funding round led by existing investor Khosla Ventures, with new strategic investments from Dai-ichi Life and SOMPO Holdings, and participation from existing investors Sozo Ventures, Rethink Impact, and AME Cloud Partners. The new round brings the company's total funding to date to more than $50 million.Alzheimer's is quickly becoming the greatest healthcare challenge of our generation, but its impact
Read More
2019 MedTech Breakthrough Award Category Winners Announced
MedTech Breakthrough, a market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market has unveiled the results of its 2019 MedTech Breakthrough Awards program, showcasing technologies and companies that drive innovation and exemplify the best in medical and health-related technology solutions across the globe.MedTech Breakthrough Awards Program OverviewThe MedTech Breakthrough Awards program is the
Read More
Flow Launches Medical-Grade Headset, Therapy App for Depression
Flow, a medical device company launches a medication-free treatment for depression comprising a brain stimulation headset and therapy app. In Europe, Flow has been approved as a Class II medical device intended for use as a treatment for depression - and is the first approved treatment of its kind in Europe available to buy and use at home.Flow BackgroundBased in Sweden, Flow was developed by clinical psychologist Daniel Mansson and neuroscientist Erik Rehn, together with a team of prominent
Read More
Altoida Raises $6.3M for Early Detection of Alzheimer’s Using AI & Augmented Reality
Altoida Inc., a digital health company using digital
biomarkers to drive better clinical outcomes for brain diseases has raised
$6.3M in Series A funding led by M Ventures, the corporate venture capital arm
of the science and technology company Merck KGaA, Darmstadt, Germany. The round
also includes participation from Grey Sky Venture Partners, VI Partners AG,
Alpana Ventures, and FYRFLY Venture Partners.
Taking Aim at the Alzheimer’s Disease Epidemic
The number of people living with
Read More
Data-Driven Precision Medicine Startup Tempus Lands $200M to Expand Into New Therapeutic Areas
Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds and accounts managed by T. Rowe Price. With this latest round, the company has raised $520 million since its founding in September 2015.Founded in 2015, Tempus has the largest
Read More
Pillo Health Raises $11M to Expand Personal Home Health Robot
Pillo Health, a Boston-based digital health company improving longevity and quality of life for patients managing their health at home has raised $11M in Series A funding, led by Stanley Black & Decker’s corporate venture capital arm with significant participation from Samsung Ventures. Existing investors, including BioAdvance, Hikma Ventures – the corporate venture capital arm of Hikma Pharmaceuticals PLC – Hackensack Meridien Health System’s Innovation Center Fund and
Read More
Talkspace Nabs $50M to Expand Telebehavioral Health Platform
Talkspace, a telebehavioral health company providing online therapy has raised $50M in funding led by Revolution Growth. Existing investors Norwest Venture Partners, Qumra Capital, Spark Capital and Compound Ventures, amongst others, will also participate in the round. Patrick Conroy of Revolution Growth will join the Talkspace board of directors. Additionally, the company announced a new partnership with Optum Health, which will expand Talkspace services to cover 5 million lives.Transforming
Read More
